Cancer Family
Cardiovascular Neoplasm
CI-CAN-00000008Explore in graph →
Non-malignant57 active trials4 approved drugs8 evidence items
- NCIt
- C4784
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000008Explore in graph →
Clinical trials
320 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05026736 | Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study | terminated | Phase 2 | 6 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT01412515 | A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma | terminated | Phase 2 | 11 | Institut National de la Santé Et de la Recherche Médicale, FranceOTHER_GOV |
| 1 |
| Jun 4, 2026 |
| clinicaltrials |
| NCT00744185 | Propranolol in Capillary Hemangiomas(HEMANGIOMA) | terminated | Phase 2 / Phase 3 | 14 | University Hospital, BordeauxOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT05479123 | Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas | terminated | Phase 4 | 52 | The University of Texas Health Science Center, HoustonOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT02408861 | Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery | terminated | Phase 1 | 79 | National Cancer Institute (NCI)NIH | 2 | Jan 21, 2026 | clinicaltrials |
| NCT05228015 | Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors | terminated | Phase 1 | 67 | Ikena OncologyINDUSTRY | 3 | Nov 18, 2024 | clinicaltrials |
| NCT00330564 | Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow | terminated | Phase 2 | 15 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 27, 2024 | clinicaltrials |
| NCT04893018 | NT-I7 for Kaposi Sarcoma in Patients With or Without HIV | terminated | Phase 1 | 8 | Fred Hutchinson Cancer CenterOTHER | 1 | Jun 27, 2024 | clinicaltrials |
| NCT01764451 | Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins | terminated | Early Phase 1 | 12 | University of New MexicoOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT04336163 | Skin Imaging to Inform Laser Treatments | terminated | N/A | 55 | University of California, IrvineOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT04020419 | Natural Berry Extract Treatment of Hemangiomas(Pediaberry) | terminated | Early Phase 1 | 12 | Gayle GordilloOTHER | 1 | Oct 23, 2023 | clinicaltrials |
| NCT02110069 | A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors | terminated | Phase 2 | 4 | Boston Children's HospitalOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT02654340 | Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)(TuScCom) | terminated | — | 20 | CENTOGENE GmbH RostockINDUSTRY | 8 | Feb 10, 2023 | clinicaltrials |
| NCT03921073 | Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma | terminated | Phase 2 | 5 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 1, 2022 | clinicaltrials |
| NCT02212015 | Evaluation of Votrient in Angiosarcoma(EVA) | terminated | Phase 2 | 26 | Heidelberg UniversityOTHER | 2 | Mar 22, 2022 | clinicaltrials |
| NCT00287495 | BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma | terminated | Phase 1 | 10 | National Cancer Institute (NCI)NIH | 1 | Dec 12, 2019 | clinicaltrials |
| NCT01752569 | A Study of Selumetinib in Patients With Kaposi's Sarcoma(SCART) | terminated | Phase 1 / Phase 2 | 19 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Feb 20, 2019 | clinicaltrials |
| NCT00020683 | A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's Sarcoma | terminated | Phase 2 | 70 | National Cancer Institute (NCI)NIH | 1 | Oct 18, 2018 | clinicaltrials |
| NCT01074437 | Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH) | terminated | Phase 2 | 9 | Seattle Children's HospitalOTHER | 1 | Oct 4, 2018 | clinicaltrials |
| NCT00686842 | PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma | terminated | Phase 1 / Phase 2 | 17 | AIDS Malignancy ConsortiumNETWORK | 1 | Jun 6, 2018 | clinicaltrials |
| NCT01055028 | Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma | terminated | Phase 2 | 18 | Stanford UniversityOTHER | 1 | Mar 26, 2018 | clinicaltrials |
| NCT00466375 | Genetic Basis of Hemangiomas | terminated | — | 300 | Medical College of WisconsinOTHER | 1 | Aug 29, 2017 | clinicaltrials |
| NCT01147601 | Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas | terminated | Early Phase 1 | 6 | Oregon Health and Science UniversityOTHER | 1 | Jul 5, 2017 | clinicaltrials |
| NCT01434849 | Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)(TiPPIH) | terminated | Phase 1 | 26 | Alice K. GongOTHER | 1 | Nov 15, 2016 | clinicaltrials |
| NCT02080416 | Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors | terminated | Early Phase 1 | 1 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jun 10, 2016 | clinicaltrials |
| NCT01743885 | Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma | terminated | Phase 3 | 55 | University Hospital, MontpellierOTHER | 1 | Jun 1, 2016 | clinicaltrials |
| NCT00555464 | Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas | terminated | Phase 2 | 8 | Medical College of WisconsinOTHER | 1 | Jun 11, 2013 | clinicaltrials |
| NCT01015300 | Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease | terminated | Early Phase 1 | 1 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | May 11, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Jul 21, 2026source: clinicaltrials